Tesamorelin research vial
Solvents / Signaling

Tesamorelin

Stabilized GHRH

$79.99TESA-10

A stabilized GHRH analog investigated for growth hormone axis stimulation.

Commonly acquired for growth-hormone axis research. Used in studies of the GH–IGF-1 axis and adipose tissue.

Bundle & save

Estimated arrival Mon, September 14 – Tue, September 15 · dispatched next business day via priority shipping
Earns 79 points $2.63 toward a future order
≥99% purity guaranteed Third-party tested Lot-specific COA Next-business-day dispatch

A stabilized GHRH analog investigated for growth hormone axis stimulation.

Supplied as a research-use-only preparation from a cGMP-compliant, ISO-certified facility and guaranteed to a minimum of 99% purity. Each lot is submitted for independent third-party analysis, and the certificate of analysis is tied to the lot code printed on the vial you receive.

Not for human or animal consumption. This compound is intended strictly for in-vitro laboratory and scientific research use. It is not approved by the FDA and is not for medical, diagnostic, or therapeutic use.

Independent literature

Published research on Tesamorelin

Peer-reviewed publications about this compound, hosted by PubMed and the original publishers. Read them there, not here.

The references below are independent, peer-reviewed publications about this compound as studied in academic and clinical research. They are provided for scientific context only. They are not evidence for any claim about this product, they do not describe this material, and their authors have no affiliation with BioStem Labs. Linking to a study is not a claim that its findings apply to anything sold here.
Tesamorelin
FormulaC221H366N72O67S
Molecular weight5136 g/mol
PubChem CID 16137828
Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy
Drugs2011 PMID 21668043
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Front Endocrinol (Lausanne)2026 PMID 42395176
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
Am J Sports Med2026 PMID 41476424
Documentation

Certificate of analysis

Independent third-party analysis for the lot on your vial — opened directly, no lookup.

Certificate of analysis

Tesamorelin · 10 mg · Lot CA0201

Purity
99.06% ±0.18%
Assay
11.80 mg
Lab ID
V251008-22 002
Date reported
Not stated
Sterility USP <61>: Pass — no growth
tesamorelin.pdf Vanguard Laboratory · ISO 17025:2017 · A2LA #6377.01.01
Open certificate →